Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Azacitidine Azacitidine 100mg Powder for injection Apotex NZ Limited Gland Pharma Limited, Visakhapatnam, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Imatinib Mylan Imatinib mesilate 119.5mg equivalent to imatinib base 100mg Film coated tablet Mylan New Zealand Limited Remedica Limited, Limassol, Cyprus
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Imatinib Mylan Imatinib mesilate 478mg equivalent to imatinib base 400mg Film coated tablet Mylan New Zealand Limited Remedica Limited, Limassol, Cyprus
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Paracetamol Suppositories Paracetamol 125mg Suppository PSM Healthcare Limited trading as API Consumer Brands PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Paracetamol Suppositories Paracetamol 250mg Suppository PSM Healthcare Limited trading as API Consumer Brands PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Sumatriptan Sumatriptan succinate 140mg equivalent to sumatriptan 100mg Film coated tablet REX Medical Limited Cipla Limited, Verna, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Sumatriptan Sumatriptan succinate 70mg equivalent to sumatriptan 50mg Film coated tablet REX Medical Limited Cipla Limited, Verna, India
|
Dated this 8th day of March 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).